P/E ratio for National Medical Care Company (4005.SR)
P/E ratio as of May 2024 (TTM): 37.9
According to National Medical Care Company's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 37.8917. At the end of 2022 the company had a P/E ratio of 19.6.
P/E ratio history for National Medical Care Company from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 19.6 | -4.93% |
| 2021 | 20.6 | -18.16% |
| 2020 | 25.2 | -7.23% |
| 2019 | 27.1 | -22.74% |
| 2018 | 35.1 | 54.23% |
| 2017 | 22.8 | -61.22% |
| 2016 | 58.7 | 208.08% |
| 2015 | 19.1 | -26.54% |
| 2014 | 25.9 | -0.02% |
| 2013 | 25.9 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.